Determination of phenylbutazone, tolbutamide and metabolites in plasma and urine using chemical ionization mass spectrometry.
Quantitative analytical procedures for the analysis of phenylbutazone and tolbutamide levels in plasma have been developed which involve the addition of deuterium labeled internal standards to plasma followed by extraction and direct sample insertion into a mass spectrometer operating under chemical ionization conditions. Peak height ratios used to calculate plasma levels were determined by using either selected ion monitoring or repetitive scan data. The scan approach was used in a related procedure for the simultaneous determination of tolbutamide and two metabolites from urine. The accuracy, precision and sensitivity of the direct sample insertion approach to drug level measurement has been determined. Examples are given of data obtained in the course of pharmacokinetic studies in which this analytical approach appears to offer advantages in the analysis of multicomponent mixtures encountered in drug-drug interaction studies.
D000818:Animals; D004347:Drug Interactions; D013058:Mass Spectrometry; D010653:Phenylbutazone / Q000097:blood / Q000378:metabolism* / Q000652:urine; D012756:Sheep; D014044:Tolbutamide / Q000097:blood / Q000378:metabolism* / Q000652:urine
D014044:Tolbutamide; D010653:Phenylbutazone